Value based pricing: Can it work?

BMJ (Online)

Volumn 347, Issue 7929, 2013, Pages

  Raftery, James ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG INDUSTRY; ECONOMIC ASPECT; FINANCIAL MANAGEMENT; FUNDING; HEALTH CARE ACCESS; HUMAN; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; UNITED KINGDOM; VALUE BASED PRICING;

COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; DRUG COSTS; ECONOMICS, PHARMACEUTICAL; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS;

EID: 84886916793     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f5941     Document Type: Article

References (21)

1. Porter M, Teisbert EO. Redefining health care. Creating value based competition on results. Harvard Business School, 2006.
2. OECD. Breakdown of gross domestic product per capita in its components. 2012. http://stats.oecd.org/Index.aspx?DatasetCode=DECOMP.
3. NHS Information Centre. Prescriptions dispensed in the community: England, statistics for 2001-2011. https://catalogue.ic.nhs.uk/publications/ prescribing/primary/pres-disp-comeng-2001-11/pres-disp-com-eng-2001-11-rep.pdf.
4. Department of Health. The PPRS: first report to parliament. 1996. http://webarchive. nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/ en/Publicationsandstatistics/Publications/AnnualReports/DH-4121847.
5. NICE. List of technologies with approved patent access schemes recommended by NICE for use in the NHS. 2013. www.nice.org.uk/aboutnice/ howwework/paslu/ListOfPatientAccessSchemesApprovedAsPartOfANICEAppraisal.jsp.
6. NICE. NICE and cancer drugs-the facts. www.nice.org.uk/newsroom/ nicestatistics/niceandcancerdrugsthefacts.jsp.
7. Raftery J, Multiple sclerosis risk sharing scheme: a costly failure. BMJ 2010;340:c1672.
8. Collins M, Latimer N. NICE's end of life decision making scheme: impact on population health. BMJ 2013;346:f1363.
9. HM Government. Coalition government: our programme for government. 2010. www.gov. uk/government/uploads/system/uploads/attachment-data/file/78977/ coalition-programme-for-government.pdf.
10. Office of Fair Trading. The pharmaceutical price regulation scheme: an OFT market study. 2007. www.oft.gov. uk/shared-oft/reports/comp-policy/oft885. pdf.
11. Department of Health. A new value-based approach to the pricing of branded medicines: government response to consultation, 16 December 2010. http://gp. dh.gov. uk/2011/09/27/government-response-to-value-based-pricing- consultation-2/.
12. Health and Sport Committee. Access to new medicines. 8th report. 2013. www.scottish. parliament.uk/S4-HealthandSportCommittee/Reports/her-13-08w.pdf.
13. Raftery J. Value based pricing-terms of reference given by the Department of Health to NICE. BMJ blogs 2013. http://blogs.bmj.com/bmj/2013/06/28/james- raftery-value-basedpricing-terms-of-reference-given-by-the-department-of-health- to-nice/.
14. Raftery J. QALYs and value based pricing. BMJ Group blogs. 2012. http://blogs.bmj.com/bmj/2012/12/21/james-raftery-qalys-and-value-based-pricing/ .
15. Raftery J. Moving to value based pricing: adjusting costs. BMJ Group blogs. 2013. http://blogs.bmj.com/bmj/2012/11/20/james-raftery-moving-to-value- based-pricing-adjustingcosts/.
16. NICE. Guide to the methods of technology appraisal. www.nice.org.uk/ aboutnice/howwework/devnicetech/guidetothemethodsoftechnologyappraisal.jsp.
17. Department of Health. NHS Constitution. 2013. www.nhs.uk/choiceintheNHS/ Rightsandpledges/NHSConstitution/Documents/2013/the-nhs-constitution-for- england-2013.pdf.
18. Illman J. Delay in pricing plan for new drugs. Health Service Journal 2013 Oct. 4. www.hsj.co.uk/news/finance/delay-in-pricing-plan-for-new-drugs/ 5063963.article#.UlUVpNKsjTo.
19. Sussex J, Towse A, Devlin N. Operationalizing value-based pricing of medicines: a taxonomy of approaches. Pharmacoeconomics 2013;31:1-10.
20. Perrson U. Value based pricing in Sweden: lessons for design? OHE briefing No 12. 2012. www.ohe.org/publications/article/value-based-pricing-in- sweden-122.cfm.
21. Department of Health. Thousands of patients to benefit from £400m cancer package. Press release 28 Sep. 2013. www.gov. uk/government/news/ thousands-of-patients-tobenefit-from-400-million-cancer-package.